ALMKT:EPA
Mauna Kea Technologies SA
€0.092
0.00%
(0.00) 1 دن
13 نومبر, 5:35:01 PM GMT +1 · EUR
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoALMKT کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
€0.09
اعلی
€0.10
کم
€0.09
مارکیٹ کی سرمایہ کاری
1.81 کروڑ
اوسط والیوم
5.41 لاکھ
والیوم
75.16 ہزار
P/E تناسب
0.79
52 ہفتے میں اعلی
€0.23
52 ہفتے کا کم
€0.07
EPS
€0.12
بقایہ شیئرز
19.53 کروڑ
ملازمین کی تعداد
56
کھولیں
€0.09
اعلی
€0.10
کم
€0.09
مارکیٹ کی سرمایہ کاری
1.81 کروڑ
اوسط والیوم
5.41 لاکھ
والیوم
75.16 ہزار
P/E تناسب
0.79
52 ہفتے میں اعلی
€0.23
52 ہفتے کا کم
€0.07
EPS
€0.12
بقایہ شیئرز
19.53 کروڑ
ملازمین کی تعداد
56
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
BigGo Finance
·
4 گھنٹے پہلے
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
3 گھنٹے پہلے
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
1 گھنٹہ پہلے
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
1 گھنٹہ پہلے
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
پروفائل
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA کے بارے میں